Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
Next >
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
Health & Science
Earnings
Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Biogen Inc
PepsiCo Inc/
IMAX Corp
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Biotech and Pharmaceuticals
Business
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Health & Science
Healthy Returns
Science
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
Business
Biotech and Pharmaceuticals
Eisai Co Ltd
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
Business News
Investment strategy
Tesla Inc
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Companies
Science
Health & Science
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Amgen Inc
Biotech and Pharmaceuticals
Business
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
Walt Disney Co
Biogen Inc
MGM Resorts International
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
Health & Science
Pharmaceuticals
Health care industry
From
CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags
Biotech and Pharmaceuticals
Business
Business News
From
CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags
Reata Pharmaceuticals Inc
AstraZeneca PLC
Business
From
CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
July 25, 2023
Tags
Business
United Parcel Service Inc
Whirlpool Corp
From
CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
July 25, 2023
Tags
Companies
Health & Science
Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Tuesday
July 18, 2023
Tags
Business
Tesla Inc
Meta Platforms Inc
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Health & Science
Health care industry
Biogen Inc
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Breaking News: Business
Science
Politics
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Health & Science
Pharmaceuticals
Regulations
From
CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
July 07, 2023
Tags
stocks
TG Therapeutics Inc
Stock markets
From
CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
July 07, 2023
Tags
Alibaba Group Holding Ltd
Levi Strauss & Co
Breaking News: Markets
From
CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023
Tags
Asia Markets
Science
Biotech and Pharmaceuticals
From
CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Eisai Co Ltd
Biotech and Pharmaceuticals
Business
From
CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
June 13, 2023
Tags
Carnival Corp
Freeport/McMoRan Inc
Zions Bancorporation NA
From
CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
June 09, 2023
Tags
Epidemics
Policy
Politics
From
CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
Alzheimer's disease
Policy
Politics
From
CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
May 15, 2023
Tags
Business
Food and drink
Eli Lilly and Co
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
Politics
Alzheimer's disease
Policy
From
CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
May 03, 2023
Tags
Market Insider
Biogen Inc
Advanced Micro Devices Inc
From
CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
May 01, 2023
Tags
Breaking News: Business
Policy
Epidemics
From
CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
April 30, 2023
Tags
Quanterix Corp
Eli Lilly and Co
Eisai Co Ltd
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.